Cathepsin L Inhibitor I features a peptide-based inhibitory motif designed to probe cysteine protease recognition. Functional groups establish key interactions in the active site and support mechanistic evaluation. Researchers assess its binding constants and conformational preferences. Applications include enzyme inhibition research, structural mapping, and selectivity analysis.
CAT No: R2713
CAS No:108005-94-3
Synonyms/Alias:Cathepsin L Inhibitor I;108005-94-3;Z-Phe-Phe-FMK;Z-Phe-Phe-Fluoromethylketone;Cathepsin L-IN-2;benzyl N-[1-[(4-fluoro-3-oxo-1-phenylbutan-2-yl)amino]-1-oxo-3-phenylpropan-2-yl]carbamate;Z-FF-FMK?;SCHEMBL9195401;BDBM110185;EX-A4898;AKOS040756455;DA-68878;HY-115733;CS-0255057;
2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
3. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.